NeuBase Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
August 11, 2022 at 08:07 am EDT
NeuBase Therapeutics, Inc. reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported net loss was USD 8.49 million compared to USD 8.66 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.29 a year ago.
For the nine months, net loss was USD 26.14 million compared to USD 18.25 million a year ago. Basic loss per share from continuing operations was USD 0.8 compared to USD 0.72 a year ago.